G Medical Innovations (GMVDF) Competitors

$0.0036 +0.00 (+1,700.00%)

As of 05/4/2026 02:45 PM Eastern

GMVDF vs. AEMD, RBOT, IVF, VBIO, and NUWE

Should you be buying G Medical Innovations stock or one of its competitors? The main competitors of G Medical Innovations include Aethlon Medical (AEMD), Vicarious Surgical (RBOT), INVO Fertility (IVF), Valion Bio, Inc. Common Stock (VBIO), and Nuwellis (NUWE). These companies are all part of the "medical equipment" industry.

How does G Medical Innovations compare to Aethlon Medical?

G Medical Innovations (NASDAQ:GMVDF) and Aethlon Medical (NASDAQ:AEMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
G Medical Innovations
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Aethlon Medical
1 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.50
: In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled Aethlon Medical'saverage media sentiment score.
Company Overall Sentiment
G Medical Innovations Neutral
Aethlon Medical Neutral
: G Medical Innovations has a beta of 43.14, meaning that its share price is 4,214% more volatile than the S&P 500. Comparatively, Aethlon Medical has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500.
: Aethlon Medical has lower revenue, but higher earnings than G Medical Innovations.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
G Medical Innovations $4.42M 0.21 -$24.63M N/A N/A
Aethlon Medical N/A N/A -$13.39M -$14.69 N/A
: G Medical Innovations' return on equity of 0.00% beat Aethlon Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
G Medical Innovations N/A N/A N/A
Aethlon Medical N/A -219.39% -164.33%
: 6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by company insiders. Comparatively, 0.7% of Aethlon Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
G Medical Innovations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Company	Overall Sentiment
G Medical Innovations	Neutral
Aethlon Medical	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
G Medical Innovations	$4.42M	0.21	-$24.63M	N/A	N/A
Aethlon Medical	N/A	N/A	-$13.39M	-$14.69	N/A

Company	Net Margins	Return on Equity	Return on Assets
G Medical Innovations	N/A	N/A	N/A
Aethlon Medical	N/A	-219.39%	-164.33%

Summary

G Medical Innovations beats Aethlon Medical on 6 of the 8 factors compared between the two stocks.

How does G Medical Innovations compare to Vicarious Surgical?

Vicarious Surgical (NYSE:RBOT) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

: Vicarious Surgical currently has a consensus target price of $7.00, suggesting a potential upside of 1,527.91%. Given Vicarious Surgical's stronger consensus rating and higher possible upside, analysts plainly believe Vicarious Surgical is more favorable than G Medical Innovations.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vicarious Surgical
1 Sell rating(s)
2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.67
G Medical Innovations
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: Vicarious Surgical has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500. Comparatively, G Medical Innovations has a beta of 43.14, meaning that its stock price is 4,214% more volatile than the S&P 500.
: G Medical Innovations' return on equity of 0.00% beat Vicarious Surgical's return on equity.
Company Net Margins Return on Equity Return on Assets
Vicarious Surgical N/A -184.13% -112.50%
G Medical Innovations N/A N/A N/A
: G Medical Innovations has higher revenue and earnings than Vicarious Surgical.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Vicarious Surgical N/A N/A -$63.22M -$6.69 N/A
G Medical Innovations $4.42M 0.21 -$24.63M N/A N/A
: 47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are held by institutional investors. 9.5% of Vicarious Surgical shares are held by company insiders. Comparatively, 37.1% of G Medical Innovations shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
: In the previous week, Vicarious Surgical had 2 more articles in the media than G Medical Innovations. MarketBeat recorded 2 mentions for Vicarious Surgical and 0 mentions for G Medical Innovations. Vicarious Surgical's average media sentiment score of 0.34 beat G Medical Innovations' score of 0.00 indicating that Vicarious Surgical is being referred to more favorably in the media.
Company Overall Sentiment
Vicarious Surgical Neutral
G Medical Innovations Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vicarious Surgical	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
G Medical Innovations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
Vicarious Surgical	N/A	-184.13%	-112.50%
G Medical Innovations	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vicarious Surgical	N/A	N/A	-$63.22M	-$6.69	N/A
G Medical Innovations	$4.42M	0.21	-$24.63M	N/A	N/A

Company	Overall Sentiment
Vicarious Surgical	Neutral
G Medical Innovations	Neutral

Summary

G Medical Innovations beats Vicarious Surgical on 6 of the 11 factors compared between the two stocks.

How does G Medical Innovations compare to INVO Fertility?

INVO Fertility (NASDAQ:IVF) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

: G Medical Innovations has a net margin of 0.00% compared to INVO Fertility's net margin of -417.02%.
Company Net Margins Return on Equity Return on Assets
INVO Fertility -417.02% N/A -92.42%
G Medical Innovations N/A N/A N/A
: INVO Fertility has a beta of 2.31, meaning that its stock price is 131% more volatile than the S&P 500. Comparatively, G Medical Innovations has a beta of 43.14, meaning that its stock price is 4,214% more volatile than the S&P 500.
: 12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 0.7% of INVO Fertility shares are owned by company insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: In the previous week, INVO Fertility had 1 more articles in the media than G Medical Innovations. MarketBeat recorded 1 mentions for INVO Fertility and 0 mentions for G Medical Innovations. INVO Fertility's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.
Company Overall Sentiment
INVO Fertility Neutral
G Medical Innovations Neutral
: INVO Fertility has higher revenue and earnings than G Medical Innovations.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
INVO Fertility $6.53M 0.47 -$9.10M -$3.15 thousand N/A
G Medical Innovations $4.42M 0.21 -$24.63M N/A N/A
: INVO Fertility presently has a consensus price target of $20.00, indicating a potential upside of 958.20%. Given INVO Fertility's stronger consensus rating and higher probable upside, research analysts clearly believe INVO Fertility is more favorable than G Medical Innovations.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INVO Fertility
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

1 Strong Buy rating(s)
2.50
G Medical Innovations
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00

Company	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-417.02%	N/A	-92.42%
G Medical Innovations	N/A	N/A	N/A

Company	Overall Sentiment
INVO Fertility	Neutral
G Medical Innovations	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.53M	0.47	-$9.10M	-$3.15 thousand	N/A
G Medical Innovations	$4.42M	0.21	-$24.63M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
G Medical Innovations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

INVO Fertility beats G Medical Innovations on 8 of the 12 factors compared between the two stocks.

How does G Medical Innovations compare to Valion Bio, Inc. Common Stock?

G Medical Innovations (NASDAQ:GMVDF) and Valion Bio, Inc. Common Stock (NASDAQ:VBIO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, profitability, analyst recommendations, risk, valuation and dividends.

: G Medical Innovations' return on equity of 0.00% beat Valion Bio, Inc. Common Stock's return on equity.
Company Net Margins Return on Equity Return on Assets
G Medical Innovations N/A N/A N/A
Valion Bio, Inc. Common Stock N/A -109.83% -69.32%
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
G Medical Innovations
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Valion Bio, Inc. Common Stock
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: 6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 4.3% of Valion Bio, Inc. Common Stock shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by insiders. Comparatively, 2.4% of Valion Bio, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
: G Medical Innovations has a beta of 43.14, indicating that its share price is 4,214% more volatile than the S&P 500. Comparatively, Valion Bio, Inc. Common Stock has a beta of 1.86, indicating that its share price is 86% more volatile than the S&P 500.
: Valion Bio, Inc. Common Stock has lower revenue, but higher earnings than G Medical Innovations.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
G Medical Innovations $4.42M 0.21 -$24.63M N/A N/A
Valion Bio, Inc. Common Stock $780K 4.07 -$8.88M N/A N/A
: In the previous week, Valion Bio, Inc. Common Stock had 1 more articles in the media than G Medical Innovations. MarketBeat recorded 1 mentions for Valion Bio, Inc. Common Stock and 0 mentions for G Medical Innovations. G Medical Innovations' average media sentiment score of 0.00 equaled Valion Bio, Inc. Common Stock'saverage media sentiment score.
Company Overall Sentiment
G Medical Innovations Neutral
Valion Bio, Inc. Common Stock Neutral

Company	Net Margins	Return on Equity	Return on Assets
G Medical Innovations	N/A	N/A	N/A
Valion Bio, Inc. Common Stock	N/A	-109.83%	-69.32%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
G Medical Innovations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Valion Bio, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
G Medical Innovations	$4.42M	0.21	-$24.63M	N/A	N/A
Valion Bio, Inc. Common Stock	$780K	4.07	-$8.88M	N/A	N/A

Company	Overall Sentiment
G Medical Innovations	Neutral
Valion Bio, Inc. Common Stock	Neutral

Summary

G Medical Innovations beats Valion Bio, Inc. Common Stock on 6 of the 10 factors compared between the two stocks.

How does G Medical Innovations compare to Nuwellis?

Nuwellis (NASDAQ:NUWE) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

: G Medical Innovations has a net margin of 0.00% compared to Nuwellis' net margin of -211.86%. G Medical Innovations' return on equity of 0.00% beat Nuwellis' return on equity.
Company Net Margins Return on Equity Return on Assets
Nuwellis -211.86% -6,094.26% -231.24%
G Medical Innovations N/A N/A N/A
: Nuwellis has a beta of 0.25, meaning that its share price is 75% less volatile than the S&P 500. Comparatively, G Medical Innovations has a beta of 43.14, meaning that its share price is 4,214% more volatile than the S&P 500.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nuwellis
1 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
G Medical Innovations
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: 3.1% of Nuwellis shares are held by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are held by institutional investors. 1.6% of Nuwellis shares are held by company insiders. Comparatively, 37.1% of G Medical Innovations shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
: Nuwellis has higher revenue and earnings than G Medical Innovations.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Nuwellis $8.27M 0.33 -$17.52M -$90.92 N/A
G Medical Innovations $4.42M 0.21 -$24.63M N/A N/A
: In the previous week, Nuwellis had 2 more articles in the media than G Medical Innovations. MarketBeat recorded 2 mentions for Nuwellis and 0 mentions for G Medical Innovations. Nuwellis' average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.
Company Overall Sentiment
Nuwellis Neutral
G Medical Innovations Neutral

Company	Net Margins	Return on Equity	Return on Assets
Nuwellis	-211.86%	-6,094.26%	-231.24%
G Medical Innovations	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nuwellis	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
G Medical Innovations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nuwellis	$8.27M	0.33	-$17.52M	-$90.92	N/A
G Medical Innovations	$4.42M	0.21	-$24.63M	N/A	N/A

Company	Overall Sentiment
Nuwellis	Neutral
G Medical Innovations	Neutral

Summary

Nuwellis and G Medical Innovations tied by winning 6 of the 12 factors compared between the two stocks.

Get G Medical Innovations News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMVDF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GMVDF vs. The Competition

Export

Metric	G Medical Innovations	Surgical & medical instruments Industry	Medical Sector	NASDAQ Exchange
Market Cap	$936K	$46.11M	$6.24B	$11.86B
Dividend Yield	N/A	1.08%	2.73%	5.21%
P/E Ratio	N/A	18.58	29.04	28.48
Price / Sales	0.21	30.72	477.10	60.43
Price / Cash	N/A	18.88	27.62	36.52
Price / Book	N/A	14.27	9.67	6.67
Net Income	-$24.63M	-$20.10M	$3.55B	$332.64M
7 Day Performance	N/A	-1.39%	1.70%	2.01%
1 Month Performance	N/A	-1.61%	5.62%	9.19%
1 Year Performance	N/A	10.93%	34.42%	39.59%

G Medical Innovations Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GMVDF G Medical Innovations	N/A	$0.00 +1,700.0%	N/A	N/A	$936K	$4.42M	N/A	72
AEMD Aethlon Medical	0.1773 of 5 stars	$2.39 -0.6%	N/A	N/A	$3.74M	N/A	N/A	10
RBOT Vicarious Surgical	1.9799 of 5 stars	$0.50 +41.0%	$7.00 +1,300.0%	N/A	$3.56M	N/A	N/A	210	Upcoming Earnings Gap Up
IVF INVO Fertility	1.162 of 5 stars	$1.93 +1.9%	$20.00 +939.0%	N/A	$3.11M	$6.94M	N/A	10
VBIO Valion Bio, Inc. Common Stock	0.5053 of 5 stars	$0.97 -6.9%	N/A	N/A	$2.80M	$780K	N/A	10	News Coverage High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GMVDF) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

G Medical Innovations (GMVDF) Competitors

GMVDF vs. AEMD, RBOT, IVF, VBIO, and NUWE

How does G Medical Innovations compare to Aethlon Medical?

Summary

How does G Medical Innovations compare to Vicarious Surgical?

Summary

How does G Medical Innovations compare to INVO Fertility?

Summary

How does G Medical Innovations compare to Valion Bio, Inc. Common Stock?

Summary

How does G Medical Innovations compare to Nuwellis?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMVDF vs. The Competition

G Medical Innovations Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

G Medical Innovations (GMVDF) Competitors

GMVDF vs. AEMD, RBOT, IVF, VBIO, and NUWE

How does G Medical Innovations compare to Aethlon Medical?

Summary

How does G Medical Innovations compare to Vicarious Surgical?

Summary

How does G Medical Innovations compare to INVO Fertility?

Summary

How does G Medical Innovations compare to Valion Bio, Inc. Common Stock?

Summary

How does G Medical Innovations compare to Nuwellis?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMVDF vs. The Competition

G Medical Innovations Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools